16
Jan

Months after announcing plans to pursue an IPO for its HIV-focused joint venture, GlaxoSmithKline says it may take a similar tack with some of its other businesses.

…read more

Source: GlaxoSmithKline mulls more spinoffs amid a widespread rethink

    

0 No comments